| Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451-456, 2014 | 624 | 2014 |
| Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas S Ryall, M Zapotocky, K Fukuoka, L Nobre, AG Stucklin, J Bennett, ... Cancer cell 37 (4), 569-583. e5, 2020 | 296 | 2020 |
| Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of Clinical Oncology 35 (25), 2934-2941, 2017 | 293 | 2017 |
| Pediatric low-grade glioma in the era of molecular diagnostics S Ryall, U Tabori, C Hawkins Acta neuropathologica communications 8, 1-22, 2020 | 251 | 2020 |
| Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas AS Guerreiro Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ... Nature Communications 10 (1), 4343, 2019 | 231 | 2019 |
| Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics LM Hoffman, M DeWire, S Ryall, P Buczkowicz, J Leach, L Miles, ... Acta neuropathologica communications 4, 1-8, 2016 | 154 | 2016 |
| Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas ASG Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, C Li, ... Nature communications 10, 2019 | 153 | 2019 |
| Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma S Ryall, R Krishnatry, A Arnoldo, P Buczkowicz, M Mistry, R Siddaway, ... Acta neuropathologica communications 4, 1-10, 2016 | 107 | 2016 |
| Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition L Nobre, M Zapotocky, V Ramaswamy, S Ryall, J Bennett, D Alderete, ... JCO precision oncology 4, 561-571, 2020 | 98 | 2020 |
| Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas H Shen, M Yu, M Tsoli, C Chang, S Joshi, J Liu, S Ryall, Y Chornenkyy, ... Neuro-oncology 22 (1), 139-151, 2020 | 55 | 2020 |
| H3 K27M mutations are extremely rare in posterior fossa group A ependymoma S Ryall, M Guzman, SK Elbabaa, B Luu, SC Mack, M Zapotocky, ... Child's Nervous System 33, 1047-1051, 2017 | 54 | 2017 |
| A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment S Ryall, U Tabori, C Hawkins Brain tumor pathology 34, 51-61, 2017 | 53 | 2017 |
| Pediatric thalamic tumors in the MRI era: a Canadian perspective P Steinbok, CV Gopalakrishnan, AR Hengel, AM Vitali, K Poskitt, ... Child's Nervous System 32, 269-280, 2016 | 46 | 2016 |
| Multiplex detection of pediatric low-grade glioma signature fusion transcripts and duplications using the NanoString nCounter system S Ryall, A Arnoldo, R Krishnatry, M Mistry, K Khor, J Sheth, C Ling, ... Journal of Neuropatholgy & Experimental Neurology 76 (7), 562-570, 2017 | 44 | 2017 |
| Epigenetic activation of a RAS/MYC axis in H3. 3K27M-driven cancer S Pajovic, R Siddaway, T Bridge, J Sheth, P Rakopoulos, B Kim, S Ryall, ... Nature communications 11 (1), 6216, 2020 | 40 | 2020 |
| Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas K Fukuoka, Y Mamatjan, R Tatevossian, M Zapotocky, S Ryall, ... Neuro-oncology 22 (10), 1474-1483, 2020 | 32 | 2020 |
| Splicing is an alternate oncogenic pathway activation mechanism in glioma R Siddaway, S Milos, AKA Vadivel, THW Dobson, J Swaminathan, S Ryall, ... Nature communications 13 (1), 588, 2022 | 18 | 2022 |
| Sarcoma subgrouping by detection of fusion transcripts using NanoString nCounter technology J Sheth, A Arnoldo, Y Zhong, P Marrano, C Pereira, S Ryall, P Thorner, ... Pediatric and Developmental Pathology 22 (3), 205-213, 2019 | 12 | 2019 |
| BRAF V600E mutant oligodendroglioma‐like tumors with chromosomal instability in adolescents and young adults K Fukuoka, Y Mamatjan, S Ryall, M Komosa, J Bennett, M Zapotocky, ... Brain Pathology 30 (3), 515-523, 2020 | 10 | 2020 |
| Relationship of BRAF V600E and associated secondary mutations on survival rate and response to conventional therapies in childhood low-grade glioma. A Lassaletta, M Mistry, A Arnoldo, S Ryall, AS Guereirro Stucklin, ... Journal of Clinical Oncology 34 (15_suppl), 10509-10509, 2016 | 9 | 2016 |
